sodium selenite has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Sattar, MA; Ahmed, MH; Asfour, IA; El-Tehewi, MM; Fathey, OM; Hegab, HM; Moustafa, NN | 1 |
| Asfour, IA; El Shazly, S; Fayek, MH; Hegab, HM; Moussa, MA; Raouf, S | 1 |
| Asfour, IA; El-Desoky, H; Fayek, M; Hegab, HM; Moussa, MA; Raouf, S; Saleh, R; Soliman, M | 1 |
3 trial(s) available for sodium selenite and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
High-dose sodium selenite can induce apoptosis of lymphoma cells in adult patients with non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Sodium Selenite | 2009 |
Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients.
Topics: Adult; Antineoplastic Agents; Apoptosis; Cells, Cultured; Female; Hematopoiesis; Humans; Lymphoma, Non-Hodgkin; Male; Neutrophils; Sodium Selenite | 2006 |
The impact of high-dose sodium selenite therapy on Bcl-2 expression in adult non-Hodgkin's lymphoma patients: correlation with response and survival.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Down-Regulation; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Sodium Selenite; Vincristine | 2007 |